<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/novel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/novel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2015-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/novel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality/"},"url":"https://clinicaltree.github.io/posts/novel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality/"}</script><title>Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Novel X-Ray Imaging Technology Allows Substantial Patient Radiation Reduction without Image Quality Impairment in Repetitive Transarterial Chemoembolization for Hepatocellular Carcinoma</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1446310800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Xiaofei Wen MD PhD</a> </em>, <em> <a href="">Xianxian Jiang MSc</a> </em>, <em> <a href="">Renfei Li MD PhD</a> </em>, <em> <a href="">Junya Zhang MSc</a> </em>, <em> <a href="">Po Yang MD PhD</a> </em>, <em> <a href="">Baozhong Shen MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1615 words"> <em>8 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To assess patient radiation dose reduction and the image quality of a new X-ray imaging technology during repetitive transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).</p><h2 id="methods"><span class="mr-2">Methods</span><a href="#methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Fifty HCC patients (36 men; 57 ± 11 years) undergoing repetitive TACE were first randomly assigned to receive a TACE treatment on a reference X-ray system or a low-dose system with advanced real-time image processing. The alternate system was used for a repeated TACE (treatment interval, 0.5–6 months). Fluoroscopy time, number of digital subtraction angiography (DSA), air kerma (AK), and dose area product (DAP) were compared between the two systems and between the two repetitive TACE. Three interventional radiologists independently rated the image quality in blinded offline readings.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Fluoroscopy time (8.7 ± 5.9 minutes vs. 8.7 ± 7.9 minutes, <em>P</em> = .981), numbers of DSA runs (6 ± 4 vs. 6 ± 4, <em>P</em> = .735), and exposure images (173 ± 86 vs. 168 ± 91, <em>P</em> = .916) were equivalent between the two systems. No statistical difference in X-ray usage was found between repeated treatments. Compared to the reference system, the technology significantly reduced AK and DAP by 48.6% (0.17 ± 0.13 Gy vs. 0.41 ± 0.36 Gy, <em>P</em> &lt; .0001) and 50.3% (77.3 ± 55.2 Gy cm 2 vs. 195.0 ± 155.5 Gy cm 2 , <em>P</em> &lt; .0001), respectively. Image quality was rated comparable between the new system and the reference, with average scores of 3.9 ± 0.3 versus 4.4 ± 0.3 in fluoroscopy and 4.5 ± 0.2 versus 4.3 ± 0.3 in DSA.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Patient radiation exposure can be substantially reduced by a factor of approximately two with the novel X-ray imaging technology while maintaining image quality.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Patients with unresectable hepatocellular carcinoma (HCC) can receive transarterial chemoembolization (TACE) as a palliative treatment . However, guided by fluoroscopy and digital subtraction angiography (DSA), the interventional radiologic procedure could result in a considerable amount of radiation which may put the patient at risk to radiation-induced skin injuries. Furthermore, because of tumor recurrence, repetitive embolization is often required , increasing the burden of cumulative radiation exposure to the patient and the clinical stuff.</p><p>In accordance with the “as low as reasonably achievable” (ALARA) principle, radiation dose should be kept at the lowest possible level when conducting radiologic procedures. However, during TACE therapies, clinically sufficient image quality might be obtained at the expense of radiation dose due to the X-ray attenuation while penetrating the abdomen during image acquisitions. Furthermore, noise and artifacts in the images, caused by breathing for instance, may necessitate additional image acquisition and increase patient irradiation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Baseline Characteristics</p><p>Age, y ∗ 57 ± 11 Sex Male 36 Female 14 Body mass index (kg/m 2 ) ∗ 23.0 ± 3.2 Repetitive TACE indication Local lipiodol loss 45 Local lesion recurrence 6 New lesion appearance 3 Treatment interval (d) † 50 (11–224)</p><p>Assessment 1 (n = 50) Assessment 2 (n = 50) Child–Pugh Score A 34 31 B 16 19 C 0 0 Barcelona clinical liver cancer staging 0 5 5 A 12 12 B 25 25 C 8 8 D 0 0</p><p>TACE, transarterial chemoembolization.</p><p>Except where indicated, data represent numbers of patients.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-technology"><span class="mr-2">Imaging Technology</span><a href="#imaging-technology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-quality-assessment"><span class="mr-2">Image Quality Assessment</span><a href="#image-quality-assessment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Image Quality Scoring Scale Used to Assess Fluoroscopy</p><p>Score Hepatic Artery Visibility to Sub-subsegmental Level Branches Intravascular Lipiodol Flow Direction and Speed Visibility Tumor Lipiodol Deposition Visibility 5 Clear Clear Clear 4 Clear Clear Fair 3 Clear Fair Fair 2 Subsegmental level, fair; sub-subsegmental level, poor Poor Poor 1 Subsegmental level, poor; sub-subsegmental level, not visible Poor Not visible 0 Not visible Not visible Not visible</p><p>Table 3</p><p>Image Quality Scoring Scale Used to Assess Digital Subtraction Angiography</p><p>Score Hepatic Artery Visibility to Sub-subsegmental Level Branches Tumor (Size, Border) and Feeding Vessel Visibility Portal Vein Visibility 5 Clear Clear Clear 4 Clear Tumor, clear; feeding vessel, fair Clear 3 Clear Fair Fair 2 Subsegmental level, clear; sub-subsegmental level, fair Poor Fair 1 Subsegmental level, clear; sub-subsegmental level, poor Tumor, poor; feeding vessel, not visible Not visible 0 Not visible Not visible Not visible</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data-collection-and-statistical-analysis"><span class="mr-2">Data Collection and Statistical Analysis</span><a href="#data-collection-and-statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/0_1s20S1076633215003232.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/0_1s20S1076633215003232.jpg" alt="Figure 1, Procedural air kerma (AK) (a) and dose area product (DAP) (b) in box plots and mean values. Box illustrates median and interquartile (first to third) range; whiskers illustrates minimum and maximum data point (excluding outliers over 1.5 box height above the third quartile)." class="lazyload" data-proofer-ignore></a></p><p>Table 4</p><p>Procedural X-Ray Usage and Patient Radiation Dose</p><p>AlluraClarity (n = 50) Reference (n = 50) Average Reduction (%)<em>P</em> Value Fluoroscopy time (min) 8.7 ± 5.9 8.7 ± 7.9 NS DSA runs 6 ± 4 6 ± 4 NS Exposure images 173 ± 86 168 ± 91 NS Total AK (Gy) 48.6 &lt;.0001 Mean ± SD 0.17 ± 0.13 0.41 ± 0.36 Median (Q1–Q3) 0.13 (0.09–0.20) 0.30 (0.21–0.48) AK–fluoroscopy (Gy) &lt;.0001 Mean ± SD 0.05 ± 0.04 0.12 ± 0.10 Median (Q1–Q3) 0.03 (0.02–0.06) 0.08 (0.07–0.14) AK–DSA (Gy) &lt;.0001 Mean ± SD 0.12 ± 0.09 0.30 ± 0.29 Median (Q1–Q3) 0.09 (0.06–0.15) 0.22 (0.15–0.31) Total DAP (Gy∙cm 2 ) 50.3 &lt;.0001 Mean ± SD 77.3 ± 55.2 195.0 ± 155.5 Median (Q1–Q3) 57.4 (45.5–101.0) 149.5 (100.6–245.8) DAP–fluoroscopy (Gy∙cm 2 ) &lt;.0001 Mean ± SD 21.8 ± 17.7 53.4 ± 43.8 Median (Q1–Q3) 15.7 (11.3–27.2) 38.1 (25.7–58.9) DAP–DSA (Gy∙cm 2 ) &lt;.0001 Mean ± SD 55.5 ± 40.4 141.5 ± 127.2 Median (Q1–Q3) 43.3 (29.3–72.4) 114.1 (72.8–155.7)</p><p>AK, air kerma; DAP, dose area product; DSA, digital subtraction angiography; NS, not significant; Q1–Q3, first to third quartile range; SD, standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/1_1s20S1076633215003232.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/1_1s20S1076633215003232.jpg" alt="Figure 2, Fluoroscopy images obtained on the same patient (a) with the reference angiography system and (b) with the new technology, showing the common hepatic artery ( solid arrow ), the proper hepatic artery ( flat-tail arrow ), and the right hepatic artery ( fishtail arrow )." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/2_1s20S1076633215003232.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NovelXRayImagingTechnologyAllowsSubstantialPatientRadiationReductionwithoutImageQualityImpairmentinRepetitiveTransarterialChemoembolizationforHepatocellularCarcinoma/2_1s20S1076633215003232.jpg" alt="Figure 3, Digital subtraction angiography images obtained during early arterial, late arterial, and parenchymal phases on (a) a patient with massive hepatocellular carcinoma, (b) a patient with nodular hepatocellular carcinoma, and (c) a patient with diffuse nodular hepatocellular carcinoma. Images (A–C) were acquired with the reference system and (D–F) with the new technology. Arrows point to the corresponding lesions." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgment"><span class="mr-2">Acknowledgment</span><a href="#acknowledgment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Arii S., Yamaoka Y., Futagawa S., et. al.: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: pp. 1224-1229.</p><li><p>2. Takayasu K., Arii S., Ikai I., et. al., Liver Cancer Study Group of Japan: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: pp. 461-469.</p><li><p>3. Llovet J.M., Bruix J.: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: pp. 429-442.</p><li><p>4. Bruix J., Sherman M.: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: pp. 1020-1022.</p><li><p>5. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer: EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. Journal of Hepatology 2012; 56: pp. 908-943.</p><li><p>6. Miller D.L., Balter S., Cole P.E., et. al.: Radiation doses in interventional radiology procedures: the RAD-IR study, Part I: overall measures of dose. J Vasc Interv Radiol 2003; 14: pp. 711-727.</p><li><p>7. Miller D., Kwon D., Bonavia G.H.: Reference levels for patient radiation doses in interventional radiology: proposed initial values for U.S. practice. Radiology 2009; 253: pp. 753-764.</p><li><p>8. Hidajat N., Wust P., Felix R., et. al.: Radiation exposure to patient and staff in hepatic chemoembolization: risk estimation of cancer and deterministic effects. Cardiovasc Intervent Radiol 2006; 29: pp. 791-796.</p><li><p>9. Livingstone R.S., Mammen T., GOPI : Evaluation of radiation dose to patients during abdominal embolizations. Indian J Med Sci 2005; 59: pp. 527-533.</p><li><p>10. Vogl T.J., Naguib N.N., Nour-Eldin N.E., et. al.: Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma. Acad Radiol 2012 Apr; 19: pp. 434-439.</p><li><p>11. Vogl T.J., Gruber-Rouh T., Eichler K., et. al.: Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results. Eur J Radiol 2013; 82: pp. 258-263.</p><li><p>12. Azizi A., Naguib N.N., Mbalisike E., et. al.: Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas 2011; 40: pp. 1271-1275.</p><li><p>13. Dekker L.R., van der Voort P.H., Simmers T.A., et. al.: New image processing and noise reduction technology allows reduction of radiation exposure in complex electrophysiologic interventions while maintaining optimal image quality: a randomized clinical trial. Heart Rhythm 2013; 10: pp. 1678-1682.</p><li><p>14. Söderman M., Holmin S., Andersson T., et. al.: Image noise reduction algorithm for digital subtraction angiography: clinical results. Radiology 2013; 269: pp. 553-560.</p><li><p>15. Racadio J., Strauss K., Abruzzo T., et. al.: Significant dose reduction for pediatric digital subtraction angiography without impairing image quality: preclinical study in a piglet model. AJR 2014; 203: pp. 904-908.</p><li><p>16. Van Strijen M.J., Grünhagen T., Mauti M., et. al.: Evaluation of a noise reduction imaging technology in iliac digital subtraction angiography: noninferior clinical image quality with lower patient and scatter dose. J Vasc Interv Radiol 2015 Mar;</p><li><p>17. Söderman M., Mauti M., Boon S., et. al.: Radiation dose in neuroangiography using image noise reduction technology: a population study based on 614 patients. Neuroradiology 2013; 55: pp. 1365-1372.</p><li><p>18. Nakamura S., Kobayashi T., Funatsu A., et. al.: Patient radiation dose reduction using an X- ray imaging noise reduction technology for cardiac angiography and intervention. Heart Vessels 2015 Apr 4;</p><li><p>19. Jago J., Collet-Billon A., Chenal C., et. al.: XRES®: adaptive enhancement of ultrasound images. Medicamundi 2002; 46: pp. 36-41.</p><li><p>20. Meuwly JY,Thiran JP,Gudinchet F. Application of adaptive image processing technique to real-time spatial compound ultrasound</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Novel%20X-Ray%20Imaging%20Technology%20Allows%20Substantial%20Patient%20Radiation%20Reduction%20without%20Image%20Quality%20Impairment%20in%20Repetitive%20Transarterial%20Chemoembolization%20for%20Hepatocellular%20Carcinoma%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnovel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Novel%20X-Ray%20Imaging%20Technology%20Allows%20Substantial%20Patient%20Radiation%20Reduction%20without%20Image%20Quality%20Impairment%20in%20Repetitive%20Transarterial%20Chemoembolization%20for%20Hepatocellular%20Carcinoma%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnovel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnovel-x-ray-imaging-technology-allows-substantial-patient-radiation-reduction-without-image-quality%2F&text=Novel%20X-Ray%20Imaging%20Technology%20Allows%20Substantial%20Patient%20Radiation%20Reduction%20without%20Image%20Quality%20Impairment%20in%20Repetitive%20Transarterial%20Chemoembolization%20for%20Hepatocellular%20Carcinoma%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/accuracy-of-mri-targeted-in-bore-prostate-biopsy-according-to-the-gleason-score-with-postprostatecto/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control—a Targeted Biopsy-Only Strategy with Limited Number of Cores</h3><div class="text-muted small"><p> Rationale and Objectives Accuracy of ultrasound-guided biopsy and Gleason score is limited, and diagnosis of insignificant cancer with Gleason score ≤6 is frequent when extended biopsy schemes are...</p></div></div></a></div><div class="card"> <a href="/posts/balancing-radiation-and-contrast-media-dose-in-single-pass-abdominal-multidetector-ct/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Balancing Radiation and Contrast Media Dose in Single-Pass Abdominal Multidetector CT</h3><div class="text-muted small"><p> Rationale and Objectives As both contrast and radiation dose affect the quality of CT images, a constant image quality in abdominal contrast-enhanced multidetector computed tomography (CE-MDCT) co...</p></div></div></a></div><div class="card"> <a href="/posts/breast-cancer-survivors/"><div class="card-body"> <em class="small" data-ts="1446310800" data-df="ll" > Oct 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Breast Cancer Survivors</h3><div class="text-muted small"><p> In this issue of Academic Radiology , authors Giess et al. evaluate screening breast magnetic resonance imaging (MRI) in women previously treated for breast cancer. The authors retrospectively revi...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/noncontrast-enhanced-magnetic-resonance-versus-computed-tomography-angiography-in-preoperative-evalu/" class="btn btn-outline-primary" prompt="Older"><p>Noncontrast-Enhanced Magnetic Resonance Versus Computed Tomography Angiography in Preoperative Evaluation of Potential Living Renal Donors</p></a> <a href="/posts/reinitiation-of-withdrawn-or-modified-neuroimaging-requests-after-collaborative-consultation/" class="btn btn-outline-primary" prompt="Newer"><p>Reinitiation of Withdrawn or Modified Neuroimaging Requests After Collaborative Consultation</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
